Answers are grounded in this paper and cite their sources.
Novel L-nucleoside analog, 5-fluorotroxacitabine, displays potent efficacy against acute myeloid leukemia
No takes yet. Share an insight, caveat, or question.
Bankar et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: